Evidence map›Paper›PMID 26418323›Full record

ReviewCurrent opinion in pediatrics2015

Epigenetics in allergic diseases.

Avery DeVries, Donata Vercelli

Abstract readReview
In one paragraph

Review in Current opinion in pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Avery DeVriesaGraduate Program in Cellular and Molecular Medicine bFunctional Genomics Laboratory, Arizona Respiratory Center cArizona Center for the Biology of Complex Diseases dDepartment of Cellular and Molecular Medicine eThe Bio5 Institute, University of Arizona, Tucson, Arizona, USA.
Donata Vercelli

Funding

Epigenetic predicators of asthma in neonatesRC1HL100800 · NHLBI · UNIVERSITY OF ARIZONA · PI VERCELLI, DONATA · 2009 to 2010
$959k
NHLBI NIH HHS RC1 HL100800NHLBI NIH HHS RC1HL100800
6 · The paper itself

Abstract

purpose of reviewAllergic diseases are among the most prevalent chronic diseases of childhood, affecting more than 7 million children in the United States. Epidemiological evidence supports the idea that the inception of allergic diseases is typically before the preschool years, even when chronic symptoms do not emerge until adulthood. The role of epigenetic mechanisms (particularly DNA methylation) in allergic disease is under active investigation because these mechanisms are known to be at the interface of gene regulation, environmental stimuli, and developmental processes, all of which are essential for the pathogenesis for asthma and allergy. This article specifically reviews genome-wide DNA methylation studies in allergic disease. RECENT

findingsDifferential DNA methylation at specific regions appears to be associated with concurrent allergic disease. A few studies have identified methylation signatures predictive of disease. SUMMARY: DNA methylation signatures have been shown to be associated with several allergic disease phenotypes, typically concurrently with disease. The few that have been found to precede diagnosis are especially interesting because they highlight an early trajectory to disease.

Indexed as

AdolescentAsthmaChildChild, PreschoolDisease SusceptibilityDNA MethylationEnvironmental ExposureEpigenomicsGene-Environment InteractionHumansPhenotypeRhinitis, AllergicUnited States

Identifiers

PMID26418323
PMCPMC4668123

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.